Lung Cancer (Enduring)

  • The Oncology interdisciplinary team is facing ongoing challenges due to rapidly evolving treatment protocols, including chemotherapy and other therapeutic modalities, alongside shifting standards of care. Identified gaps include the inconsistent application of evidence-based guidelines resulting in incongruent resources. Staff who care for oncology patients face this and require additional resources and support to effectively manage patient care.

Target Audience

  • Allied Health Professionals
  • Nurses
  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Pharmacist

Learning Objectives

Identifying Key Disciplines involved in Lung Cancer Care. 

Describing diagnostic steps and treatment options for Lung Cancer. 

Analyzing factors that influence care decisions. Including clinical and Psychosocial aspects. 

Recognizing Oncologic Emergencies related to Lung Cancer 

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Registration Opens: 
08/28/2025
Registration Expires: 
08/27/2027
Part of: 
2025 Duke Cancer Institute - Oncology Interdisciplinary Rounds [Enduring]
Rating: 
0
Virtual, NC
United States
  • Dr. James Scott Smith, MD;
  • Margaret Rand, PharmD;
  • Mallory Tassone, NP;
  • Kasey Watson, NP-C;
  • Nancy Pulliam, RN;
  • Marlena Parson, NP

No financial relationships to disclose

  • ACPE - Pharmacist
  • AMA PRA Category 1 Credit(s)
  • ANCC
  • IACET CEU
  • Attendance

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)™
Please login or register to take this course.